Skip to main content

Range Cancer Therapeutics ETF

Open-end / ETF
Registrant
ETF Series Solutions
Class ticker
CNCR
Net Assets
$8,928,266
Holdings
76
Latest Report
Feb 28, 2025

Net Assets Over Time

Holdings · 76

Export CSV
Showing 1–50 of 76 holdings by value · page 1 of 2
Holding Balance Value % of Fund Open
SpringWorks Therapeutics Inc
4,426 $255,646 2.86%
Blueprint Medicines Corp
1,824 $176,144 1.97%
Vor BioPharma Inc
155,827 $168,293 1.88%
Merus NV
3,136 $147,674 1.65%
Arcellx Inc
2,045 $132,557 1.48%
Nuvalent Inc
1,404 $105,272 1.18%
Day One Biopharmaceuticals Inc
11,547 $104,616 1.17%
RAPT Therapeutics Inc
83,716 $95,436 1.07%
iTeos Therapeutics Inc
13,008 $94,438 1.06%
Adicet Bio Inc
104,924 $94,306 1.06%

Showing the top 50 of 76 holdings. Create a free account to see every holding and download the CSV.